Skip to content

The effect of proton pump inhibitor on quality of life after gastrointestinal surgery

The effect of proton pump inhibitor on quality of life after gastrointestinal surgery - The effect of PPI on QOL after GI surgery

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000005326
Enrollment
690
Registered
2011-03-28
Start date
2011-03-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

digestive disease which is indicated for surgery

Interventions

lansoprazole 15 mg per oral per day for 8 weeks lansoprazole 30 mg per oral per day for 8 weeks

Sponsors

Department of Surgery, The Jikei University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The patients with digestive disease whichi are indicated for surgery

Exclusion criteria

Exclusion criteria: Patients younger than 20 year old

Design outcomes

Primary

MeasureTime frame
To evaluate the difference of the effectiveness of lansoprazole 15 mg and 30 mg on quality of life after digestive surgery using gastrointestinal symptom rating scale

Countries

Japan

Contacts

Public ContactTakeshi Gocho

Department of Surgery, Gastrointestinal Surgery

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026